Results 11 to 20 of about 12,584 (301)

Dyslipidemias in diabetes

open access: yesСахарный диабет, 2004
Cardiovascular diseases (CVD) are responsible for 75% of the morbidity and mortality in patients with type 2 diabetes. Diabetes accelerates plaque formation and progression in coronary, cerebrovascular and peripheral arteries.
HELENA W RODBARD
doaj   +3 more sources

Dislipidemias e antipsicóticos atípicos Dyslipidemias and atypical antipsychotics

open access: yesJornal Brasileiro de Psiquiatria, 2006
OBJETIVO: Um progressivo número de evidências surge associando o uso de antipsicóticos atípicos a dislipidemias, situação pouco atentada por considerável número de psiquiatras e preditora importante de doenças cardiovasculares (DCVs) e de ...
Edilberto Amorim de Cerqueira Filho   +3 more
doaj   +2 more sources

Mixed dyslipidemias in primary care patients in France

open access: yesVascular Health and Risk Management, 2012
Laurent Laforest1, Baishali M Ambegaonkar2, Thierry Souchet3, Vasilisa Sazonov2, Eric Van Ganse11Lyon University, Lyon, France; 2Merck and Co Inc, Whitehouse Station, NJ, USA; 3Merck, Sharp & Dohme, Paris, FranceObjective: To determine the ...
Laforest L   +4 more
doaj   +3 more sources

Is long-term PM1 exposure associated with blood lipids and dyslipidemias in a Chinese rural population? [PDF]

open access: yesEnvironment International, 2020
Background: Air pollution has been shown to be associated with blood lipid levels. However, studies on long-term ambient particulate matter with aerodynamic diameter ≤1 μm (PM1) exposure in high-exposure areas are still limited.
Shuyuan Mao   +13 more
doaj   +2 more sources

Development of dyslipidemias in a cohort of Mexican adult patients with HIV/AIDS under highly active antiretroviral therapy

open access: yesMexican Journal of Medical Research ICSA
Dyslipidemias are comorbidities in seropositive patients under highly active antiretroviral therapy (HAART), which increase their risk of complications and reduce their life expectancy.
Guadalupe López-Rodríguez   +2 more
doaj   +3 more sources

Potential of Fruits to Improve Dyslipidemias: A Pilot Review

open access: yesVascular Health and Risk Management
Miguel Angel Flores Flores,1,* Luis Antonio Flores Flores,2,* Serafín Dernali Romero Yupanqui3,* 1Faculty of Food Industry, Universidad Nacional de la Amazonía Peruana, Iquitos, Maynas, Loreto, 16002, Perú; 2Faculty of Chemical ...
Flores Flores MA   +2 more
doaj   +2 more sources

Exome sequencing in suspected monogenic dyslipidemias [PDF]

open access: yes, 2015
Exome sequencing is a promising tool for gene mapping in Mendelian disorders.
Kawashiri, M.   +39 more
core   +3 more sources

Diabetes Dyslipidemia [PDF]

open access: yesDiabetes Therapy, 2016
Diabetes mellitus is associated with a considerably increased risk of premature atherosclerotic cardiovascular disease. Intensive glycemic control has essentially failed to significantly improve cardiovascular outcomes in clinical trials. Dyslipidemia is common in diabetes and there is strong evidence that cholesterol lowering improves cardiovascular ...
Schofield, Jonathan D   +4 more
openaire   +2 more sources

Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism [PDF]

open access: yesEndocrine Connections, 2022
Hypothyroidism is often associated with elevated serum levels of total cholesterol, LDL-C and triglycerides. Thyroid hormone (TH) affects the production, clearance and transformation of cholesterol, but current research shows that thyroid-stimulating hormone (TSH) also participates in lipid metabolism independently of TH.
Huixing Liu, Daoquan Peng
openaire   +2 more sources

Network Medicine Approach in Prevention and Personalized Treatment of Dyslipidemias

open access: yes, 2020
Dyslipidemias can affect molecular networks underlying the metabolic homeostasis and vascular function leading to atherogenesis at early stages of development.
Faenza M.   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy